FDA NDC Directory · JSON-LD · Markdown
NDC 72888-099 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE
| Labeler / Manufacturer | Advagen Pharma Ltd. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA216321 |
| Dosage form / route | TABLET, EXTENDED RELEASE · ORAL |
| Active ingredients | POTASSIUM CHLORIDE (1500 mg/1) |
| Marketing started | 20230616 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).